By BY VIRGINIA HUGHES from NYT Health
https://ift.tt/3AG4mlt
Jazz Pharmaceuticals brought in more than $1.7 billion last year selling GHB to narcolepsy patients. With the new approval, sales could soar.
F.D.A. Approves GHB, a ‘Date Rape’ Drug, for Rare Sleeping Disorder
By BY VIRGINIA HUGHES from NYT Health
https://ift.tt/3AG4mlt
Jazz Pharmaceuticals brought in more than $1.7 billion last year selling GHB to narcolepsy patients. With the new approval, sales could soar.
No comments:
Post a Comment